Plant ID: NPO14474
Plant Latin Name: Klasea sogdiana
Taxonomy Genus: Klasea
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
354320
Plant-of-the-World-Online:
n.a.
RECQL; ALDH1A1; HSD17B2; | |
ACHE; | |
CA7; CA4; CA12; | |
ALDH2; | |
HIF1A; | |
NPC1; RAB9A; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Oxidoreductase | ALDH2 | Aldehyde dehydrogenase | P05091 | CHEMBL1935 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 3.528E-12 | 7.682E-08 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.870E-08 | 8.144E-05 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, HSD17B2, NPC1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.442E-08 | 1.071E-04 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 4.532E-08 | 1.233E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 8.300E-08 | 1.506E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 8.300E-08 | 1.506E-04 | CYP1A2, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.714E-07 | 2.871E-04 | CA12, CA4, CA7 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.997E-07 | 7.668E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.494E-06 | 1.414E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.235E-06 | 1.946E-03 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.373E-06 | 1.987E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.664E-06 | 2.148E-03 | CA12, CA4, CA7 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 3.374E-06 | 2.449E-03 | CYP1A2, CYP2C9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.923E-06 | 3.353E-03 | CA12, CA4, CA7 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.764E-06 | 3.692E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 1.179E-05 | 6.699E-03 | CYP1A2, CYP2D6 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 3.992E-05 | 1.932E-02 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, HSD17B2, RAB9A |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.721E-07 | 4.267E-06 | CYP2C9, CYP2D6, CYP1A2, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.233E-06 | 1.520E-05 | CYP2C9, CYP1A2, CYP2C19 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.306E-07 | 4.267E-06 | CA12, CA4, CA7 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.450E-05 | 1.341E-04 | CYP2C9, CYP1A2, ALDH1A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.057E-05 | 1.522E-04 | CYP2C9, CYP2D6, CYP1A2 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 7.406E-05 | 3.915E-04 | CYP2C9, CYP2D6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.917E-05 | 1.799E-04 | CYP2C9, CYP1A2, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.720E-04 | 7.954E-04 | CYP2C9, ALDH2, HSD17B2, CYP1A2, ALDH1A1, CYP2C19 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 4.028E-04 | 1.656E-03 | ALDH2, CYP1A2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.673E-04 | 3.254E-03 | CYP2C9, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 8.471E-04 | 3.134E-03 | CYP1A2, HSD17B2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | ALDH2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Substance dependence | F10-F19 | ALDH2; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A; |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ALDH2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |